ZFIN ID: ZDB-PUB-200125-8
Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases
Hayashi, K., Teramoto, R., Nomura, A., Asano, Y., Beerens, M., Kurata, Y., Kobayashi, I., Fujino, N., Furusho, H., Sakata, K., Onoue, K., Chiang, D.Y., Kiviniemi, T.O., Buys, E., Sips, P., Burch, M.L., Zhao, Y., Kelly, A.E., Namura, M., Kita, Y., Tsuchiya, T., Kaku, B., Oe, K., Takeda, Y., Konno, T., Inoue, M., Fujita, T., Kato, T., Funada, A., Tada, H., Hodatsu, A., Nakanishi, C., Sakamoto, Y., Tsuda, T., Nagata, Y., Tanaka, Y., Okada, H., Usuda, K., Cui, S., Saito, Y., MacRae, C.A., Takashima, S., Yamagishi, M., Kawashiri, M.A., Takamura, M.
Date: 2020
Source: Cardiovascular research   116(13): 2116-2130 (Journal)
Registered Authors: Buys, Eva Plovie, Kobayashi, Isao, MacRae, Calum A.
Keywords: none
MeSH Terms: none
PubMed: 31977013 Full text @ Cardiovasc. Res.
ABSTRACT
The genetic cause of cardiac conduction system disease (CCSD) has not been fully elucidated. Whole-exome sequencing (WES) can detect various genetic variants; however, the identification of pathogenic variants remains a challenge. We aimed to identify pathogenic or likely pathogenic variants in CCSD patients by using WES and 2015 American College of Medical Genetics and Genomics (ACMG) standards and guidelines as well as evaluating the usefulness of functional studies for determining them.
We performed WES of 23 probands diagnosed with early-onset (<65 years) CCSD and analyzed 117 genes linked to arrhythmogenic diseases or cardiomyopathies. We focused on rare variants (minor allele frequency < 0.1%) that were absent from population databases. Five probands had protein truncating variants in EMD and LMNA which were classified as "pathogenic" by 2015 ACMG standards and guidelines. To evaluate the functional changes brought about by these variants, we generated a knock-out zebrafish with CRISPR-mediated insertions or deletions of the EMD or LMNA homologs in zebrafish. The mean heart rate and conduction velocities in the CRISPR/Cas9-injected embryos and F2 generation embryos with homozygous deletions were significantly decreased. Twenty-one variants of uncertain significance were identified in 11 probands. Cellular electrophysiological study and in vivo zebrafish cardiac assay showed that 2 variants in KCNH2 and SCN5A, 4 variants in SCN10A, and 1 variant in MYH6 damaged each gene, which resulted in the change of the clinical significance of them from "Uncertain significance" to "Likely pathogenic" in 6 probands.
Of 23 CCSD probands, we successfully identified pathogenic or likely pathogenic variants in 11 probands (48%). Functional analyses of a cellular electrophysiological study and in vivo zebrafish cardiac assay might be useful for determining the pathogenicity of rare variants in patients with CCSD. SCN10A may be one of the major genes responsible for CCSD.
Whole-exome sequencing (WES) may be helpful in determining the causes of cardiac conduction system disease (CCSD), however, the identification of pathogenic variants remains a challenge. We performed WES of 23 probands diagnosed with early-onset CCSD, and identified 12 pathogenic or likely pathogenic variants in 11 of these probands (48%) according to the 2015 ACMG standards and guidelines. In this context, functional analyses of a cellular electrophysiological study and in vivo zebrafish cardiac assay might be useful for determining the pathogenicity of rare variants, and SCN10A may be one of the major development factors in CCSD.
ADDITIONAL INFORMATION No data available